Dr. Maria Rueda-Lara is the Medical Director of Psycho-Oncology at University of Miami/Sylvester, South Florida’s only NCI-designated Comprehensive Cancer Center and the Medical Director, Consult Behavioral Health Services at University of Miami Hospital (UHT).

She specializes in the co-morbidity and psychiatric manifestations of cancer. At UM, she leads the training of medical students, residents, fellows, as well as psychology practicum students in the field of psycho-oncology. Dr. Maria Rueda-Lara is an Assistant Clinical Professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami (UM) Miller School of Medicine in Miami, Florida. She is Board Certified by the American Board of Psychiatry and Neurology in General Psychiatry with an added qualification in the Subspecialty of Consultation-Liaison. She completed her residency training in Psychiatry at Rutgers/Robert Wood Johnson Medical School in New Jersey and her fellowship in Consultation Liaison/Psycho-Oncology at Memorial Sloan Kettering/Weill Cornell Medical College in New York. She is also a Fellow of the Academy of Consultation Liaison Psychiatry and the American Psychiatric Association. She has given presentations both locally and nationally in her field. Her research interests are neurocognitive symptoms in cancer treatment, delirium, and the psychiatric aspects of bone marrow transplantation.

JOIN HERE!

OBJECTIVES

At the end of the presentation, participants will be able to:

• Compare the distinct stages of the HSCT process and the pertinent psychiatric challenges that could accompany each stage.
• All participants, especially those with limited experience working with HSCT patients will walk away with a nuanced approach of evaluating and assessing the psychiatric needs of HSCT patients.
• Collect a broad view of pharmacological and non-pharmacological management strategies for HSCT patients.

FACULTY DISCLOSURES:

PLANNING COMMITTEE DISCLOSURE
Dr. Lekakis has indicated that he has no relevant financial relationships with commercial interests.
FACULTY DISCLOSURE
Dr. Rueda-Lara has indicated that she has no relevant financial relationships with commercial interests:

All the relevant financial relationships for these individuals have been mitigated.

TARGET AUDIENCE:
Faculty, Primary Care Physicians, APRNs, PharmD

ACCREDITATION:
The University of Miami Leonard M. Miller School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION:
The University of Miami Leonard M. Miller School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.